Evidence map›Paper›PMID 41063179›Full record

ArticleCell communication and signaling : CCS2025

BMAL1 modulation alleviates inflammatory responses in monocytes by targeting the Fis1-mediated mitochondrial unfolded protein response in high-altitude hypoxia.

Yi-Ling Ge, Jin Xu, Yue Cai, Bin Zhang, Si-Yuan He, Pei-Jie Li, Ying-Rui Bu, Lin Zhang, Zhi-Bin Yu, Heng Ma and 3 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yi-Ling Ge *Department of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Jin Xu *Department of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Yue Cai *Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi Province, 710032, China.
Bin ZhangDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Si-Yuan HeDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Pei-Jie LiDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Ying-Rui BuDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Lin ZhangDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Zhi-Bin YuDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China.
Heng MaDepartment of Physiology, Department of Pathophysiology, School of Basic Medical Sciences, Air Force Medical University, Xi'an, Shaanxi Province, 710032, China.
Yong LiuDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China. liuyong@fmmu.edu.cn.
Xiong-Wen ChenSchool of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. xchen001@me.com.
Man-Jiang XieDepartment of Aerospace Physiology, Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, 169 Changle West Road, Xi'an, Shaanxi Province, 710032, China. xiemanjiang@fmmu.edu.cn.

Funding

National Key Research and Development Program of China 2020YFA0803603 and 2021YFA1301402National Natural Science Foundation of China 82072101
6 · The paper itself

Abstract

backgroundHypoxia-induced inflammation has been implicated in the progression of high-altitude illnesses. Mitochondria are key organelles for oxygen metabolism and inflammation that are controlled by circadian clocks. However, little is known regarding how circadian clocks sense hypoxic signals and trigger downstream mitochondrial responses.

methodsHuman participants and mice were exposed to a real or simulated high-altitude setting of 5500 m. Multichannel fluorescence intravital microscopy was used for in vivo molecular imaging of inflammation. Bioinformatics analysis, myeloid-specific knockout mice, and RAW 264.7 cells were used to investigate the underlying inflammatory mechanisms.

resultsWe found that high-altitude hypoxia induced dynamic inflammatory activity in monocytes, characterized by significantly increased levels of cytokines (interleukin-6 [IL-6], IL-1β and monocyte chemoattractant protein-1) after acute (3-day) exposure, which returned to control levels after a prolonged (30-day) exposure. Bioinformatics analysis revealed that the core circadian transcription factor brain and muscle Arnt-like 1 (BMAL1) correlated positively with hypoxia-induced inflammation in monocytes. Mechanistically, BMAL1 induced NOD-like receptor protein 3 inflammasome activation in monocytes by targeting the Fis1-mediated mitochondrial unfolded protein response. Basic helix-loop-helix family member E40, a hypoxic stress-responsive transcription factor, directly promoted Bmal1 transcription and triggered inflammation in monocytes. In contrast, myeloid-specific deletion of BMAL1 alleviated the inflammatory activity of monocytes and circulating inflammation, both in vitro and in vivo, under high-altitude hypoxia.

conclusionsOur findings indicate that transcriptional activation of Bmal1 in monocytes can potentially serve as a novel biomarker of hypoxia-induced inflammation. Our findings also suggest a novel approach for modulating the intrinsic clock, which might render organisms less vulnerable to high-altitude hypoxia.

Indexed as

AltitudeARNTL Transcription FactorsHypoxiaInflammationMembrane ProteinsMitochondriaMitochondrial ProteinsMonocytesUnfolded Protein ResponseAnimalsHumansMaleMiceMice, Inbred C57BLMice, KnockoutRAW 264.7 CellsARNTL Transcription FactorsBMAL1 protein, humanFIS1 protein, mouseMembrane ProteinsMitochondrial ProteinsBMAL1High-altitude hypoxiaInflammatory responseMitochondrial unfolded protein response

Identifiers

PMID41063179
PMCPMC12505587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.